Latest News

There’s a real sense of optimism around new ways of tackling lung cancer

“I lost both parents to lung cancer. The doctors did what they could, but treatments back then were not what they are today. Lung cancer is a formidable opponent. Young researchers should take this opportunity to learn from the best – families like us are willing them to succeed.” These were the words of one […]

Read More

New biomarker identifies uveal melanoma patients at high risk for metastasis

MIAMI, March 1, 2016– A study by J. William Harbour, M.D., associate director for Basic Research and leader of the Eye Cancer Site Disease Group at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues published today in Clinical Cancer Research details the discovery of a biomarker that puts […]

Read More

Pancreatic cancer found to be four separate diseases

Scientists have discovered pancreatic cancer can be divided into four separate types, paving the way for more accurate diagnosis and treatment. Researchers said the findings were a “launch pad” to look for new treatments, and could help doctors better understand which treatments are likely to work for each type of the disease. Dr Emma Smith, […]

Read More

Groundbreaking discovery made use skin cells to kill cancer

In a first for medical science, University of North Carolina at Chapel Hill pharmacy researchers turn skin cells into cancer-hunting stem cells that destroy brain tumors known as glioblastoma — a discovery that can offer, for the first time in more than 30 years, a new and more effective treatment for the disease. The technique, […]

Read More

Consensus on genomic classification of bladder cancer makes progress

The genomic revolution that followed the unraveling of the human genome has led to a push to classify cancer according to genetic and molecular – rather than cell and tissue – features. While some areas like breast cancer have made huge progress in this movement, bladder cancer is a relative latecomer. To make progress in […]

Read More

Model shows cancer’s birth and spread from single cell

The discovery – reported in a Science paper – could change the way we understand melanoma and other cancers, and could lead to drugs that prevent cancer by blocking the genes that trigger this key event. It resolves a mystery that has been puzzling cancer researchers: why some cells in the body carry gene mutations […]

Read More

Coming ever closer – first PARP inhibitor licensed in Europe

Designed to target cancers in people carrying inherited faults in the BRCA1 or BRCA2 genes, PARP inhibitors have been tested in clinical trials for patients with breast, ovarian and prostate cancer caused by these genetic flaws. However, the journey from the lab to the clinic has been far from smooth, and the results have been […]

Read More